The LDN Aware section is your worldwide gateway to Low Dose Naltrexone information, resources and events. LDN Aware is a global volunteer group devoted entirely to spreading knowledge and raising public awareness of LDN as a treatment for auto immune conditions.
We work with doctors, patients, pharmacists, charities and organisations, providing information and resources for people wishing to obtain an LDN prescription. We have members from 167 countries and have helped over 14,000 people since 2004, it is our goal to continue to help as many people as possible. List of LDN Research Trust countries.
We strive to provide everything from the most up to date research studies to connecting patients with doctors in their areas who prescribe LDN to annual conferences and our newsletter, we are a primary resource for both patients and medical professionals, globally.
LDN is currently being used to treat 174+ auto immune conditions ranging from cancer and MS to Fibromyalgia/CFS/ME to Crohn’s and HIV/AIDS.
Naltrexone is a class of drug known as an opiate antagonist. Its normal use is in treating addiction to opiate drugs such as heroin or morphine. The dose used for this purpose is usually between 50 and 300mg daily.
Low-dose Naltrexone (LDN) has been used in the treatment of autoimmune diseases in the USA since 1985, but is relatively new in the United Kingdom and Europe. The LDN information pack can be downloaded.
The LDN method was devised and subsequently developed by the late Dr Bernard Bihari, a Neurophysician from New York, USA who passed away on May 16th 2010. Dr Bihari was qualified in Internal Medicine, Psychiatry and Neurology, and we hope to honour him by continuing with his pioneering work.